Cargando…
SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection results in coagulation activation although it is usually not associated with consumption coagulopathy. D‐dimers are also commonly elevated despite systemic hypofibrinolysis. To understand these unusual features of coronavirus dis...
Autores principales: | Toomer, Kevin H., Gerber, Gloria F., Zhang, Yifan, Daou, Laetitia, Tushek, Michael, Hooper, Jody E., Francischetti, Ivo M. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188457/ https://www.ncbi.nlm.nih.gov/pubmed/37206290 http://dx.doi.org/10.1002/jha2.654 |
Ejemplares similares
-
Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID‐19 infection
por: Fisher, Lori‐Ann, et al.
Publicado: (2023) -
A phase III, randomised, double‐blind, multi‐national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
por: Jang, Jun Ho, et al.
Publicado: (2022) -
Impact of age‐dependent red blood cell parameters on α‐globin gene genotyping in children
por: Nissen, Peter H., et al.
Publicado: (2022) -
Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023) -
UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease
por: Buka, Richard J, et al.
Publicado: (2022)